Inform Genomics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Inform Genomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011045
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, lung, or ovarian cancer. It utilizes a proprietary analytic platform to develop genomic-based, precision medicine products. Inform Genomics’ Mucosit is a product candidate that helps physicians to identify and target only the high-risk group. The company collaborates with biopharmaceutical companies to evaluate the risk for chemotherapy-induced nausea and vomiting in patients, who receive certain moderately emetogenic chemotherapy regimens and standard antiemetic therapy. Inform Genomics is headquartered in Boston, Massachusetts, the US.

Inform Genomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Inform Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Inform Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Inform Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Inform Genomics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Inform Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Inform Genomics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Inform Genomics to Raise USD1.4 Million in Venture Financing 10
Inform Genomics Raises USD2.6 Million in Venture Financing 11
Inform Genomics Raises Additional USD0.36 Million in Venture Financing 12
Inform Genomics Raises US$1.2 Million In Venture Financing 13
Inform Genomics Inc – Key Competitors 14
Inform Genomics Inc – Key Employees 15
Inform Genomics Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Inform Genomics Inc, Medical Equipment, Key Facts 2
Inform Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Inform Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Inform Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Inform Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Inform Genomics Inc, Deals By Market, 2011 to YTD 2017 8
Inform Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Inform Genomics to Raise USD1.4 Million in Venture Financing 10
Inform Genomics Raises USD2.6 Million in Venture Financing 11
Inform Genomics Raises Additional USD0.36 Million in Venture Financing 12
Inform Genomics Raises US$1.2 Million In Venture Financing 13
Inform Genomics Inc, Key Competitors 14
Inform Genomics Inc, Key Employees 15
Inform Genomics Inc, Other Locations 16

★海外企業調査レポート[Inform Genomics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Cumberland Insurance Group:企業の戦略・SWOT・財務情報
    The Cumberland Insurance Group - Strategy, SWOT and Corporate Finance Report Summary The Cumberland Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • The Williams Companies Inc (WMB):企業の財務・戦略的SWOT分析
    The Williams Companies Inc (WMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Gebr. Heinemann SE & Co KG:企業の戦略・SWOT・財務分析
    Gebr. Heinemann SE & Co KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • BARMER GEK:企業の戦略的SWOT分析
    BARMER GEK - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Fubon Insurance Co., Ltd.:企業の戦略的SWOT分析
    Fubon Insurance Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ampac Packaging, LLC:企業の戦略・SWOT・財務情報
    Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report Summary Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Synthetic Biologics Inc (SYN):企業の財務・戦略的SWOT分析
    Summary Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company’s pipeline products include SYN-004 and SYN-010. Its SYN-010 is a proprietary, modified-release formulation which is …
  • Sir Robert McAlpine Ltd:企業の戦略的SWOT分析
    Sir Robert McAlpine Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Virgin Active Limited:企業の戦略・SWOT・財務情報
    Virgin Active Limited - Strategy, SWOT and Corporate Finance Report Summary Virgin Active Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Glencore Plc:企業のM&A・事業提携・投資動向
    Glencore Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Glencore Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • IHI Aerospace Co Ltd:企業の戦略・SWOT・財務情報
    IHI Aerospace Co Ltd - Strategy, SWOT and Corporate Finance Report Summary IHI Aerospace Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sulzer Ltd (SUN)-エネルギー分野:企業M&A・提携分析
    Summary Sulzer Ltd (Sulzer) is an industrial engineering company that manufactures and supplies pump equipment. It offers mixers, compressors, agitators and aeration equipment. The company provides repair and maintenance service solutions for turbines, pumps, compressors, motors, and generators. Sul …
  • Genome British Columbia:医療機器:M&Aディール及び事業提携情報
    Summary Genome British Columbia (Genome BC) is a non-profit medical research organization that conducts genomics and proteomics research, and offers science and technology solutions. The organization provides prognostic, new diagnostic, and therapeutic tools for use in personalized medicine. It also …
  • Xhale Inc:製品パイプライン分析
    Summary Xhale Inc (Xhale) is a medical technology company that develops and commercializes patient-centric monitoring solutions for the healthcare industry. The company offers platforms such as SMART and assurance platforms. Its products include therapeutic drug monitoring, metabolic pathway assessm …
  • BBB Technologies Inc:企業の製品パイプライン分析
    Summary BBB Technologies Inc (BBB Tech) is a development-stage medical technology company that develops medical devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. It discovers and develops single-drop and mobile integrated diagnostic tools for blo …
  • Brazil Fast Food Corp.:企業の戦略・SWOT・財務情報
    Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report Summary Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CryoTherapeutics Gmbh-医療機器分野:企業M&A・提携分析
    Summary CryoTherapeutics GmbH (CryoTherapeutics) is a medical equipment company that offers systemic drug based approach in combination with a localised device-based therapy. The company’s proprietary cryotherapy system is used for the treatment of coronary artery disease that causes heart attacks. …
  • Public Financial Holdings Ltd (626)
    Public Financial Holdings Ltd (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Huesker Synthetic Gmbh
    Huesker Synthetic Gmbh - Strategy, SWOT and Corporate Finance Report Summary Huesker Synthetic Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PT Dirgantara Indonesia:企業の戦略・SWOT・財務情報
    PT Dirgantara Indonesia - Strategy, SWOT and Corporate Finance Report Summary PT Dirgantara Indonesia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆